Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care

Jennifer G McIntosh; Jesse Minshall; Sibel Saya; Adrian Bickerstaffe; Nadira Hewabandu; Ashleigh Qama; Jon D Emery

doi:10.3399/bjgp19X706841

Research

Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care

Jennifer G McIntosh, Jesse Minshall, Sibel Saya, Adrian Bickerstaffe, Nadira Hewabandu, Ashleigh Qama and Jon D Emery

British Journal of General Practice 2019; 69 (689): e836-e842. DOI: https://doi.org/10.3399/bjgp19X706841

Jennifer G McIntosh

Centre for Cancer Research and Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jesse Minshall

Western Health, Melbourne, Australia.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sibel Saya

Centre for Cancer Research and Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Adrian Bickerstaffe

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Australia.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nadira Hewabandu

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Australia.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ashleigh Qama

WHO Collaborating Centre for Viral Hepatitis, Doherty Institute, Melbourne, Australia.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jon D Emery

Centre for Cancer Research and Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia; Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, UK.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info
eLetters
PDF

RCGP login

**Members, we are currently experiencing an access issue. While we resolve this, please login at MyRCGP and return to BJGP to access content.**

Subscriber login

Enter your BJGP login information below.

Log in using your username and password

Username *

Enter your British Journal of General Practice username.

Password *

Enter the password that accompanies your username.

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.

If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

Subscribe to the Journal - Subscribe to the print and/or online journal.

Previous ArticleNext Article

In this issue

British Journal of General Practice

Vol. 69, Issue 689

December 2019

Table of Contents
Index by author

Download PDF

Download PowerPoint

Article Alerts

User Name *

Password *

Or,
sign in or create an account with your email address

Email *

Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care

Message Subject (Your Name) has forwarded a page to you from British Journal of General Practice

Message Body (Your Name) thought you would like to see this page from British Journal of General Practice.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care

Jennifer G McIntosh, Jesse Minshall, Sibel Saya, Adrian Bickerstaffe, Nadira Hewabandu, Ashleigh Qama, Jon D Emery

British Journal of General Practice 2019; 69 (689): e836-e842. DOI: 10.3399/bjgp19X706841

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care

Jennifer G McIntosh, Jesse Minshall, Sibel Saya, Adrian Bickerstaffe, Nadira Hewabandu, Ashleigh Qama, Jon D Emery

British Journal of General Practice 2019; 69 (689): e836-e842. DOI: 10.3399/bjgp19X706841

Share This Article: